Skip to main content
Top
Published in: Cancer Imaging 1/2014

Open Access 01-12-2014 | Review

Prognostic factors in advanced pharyngeal and oral cavity cancer; significance of multimodality imaging in terms of 7th edition of TNM

Author: Maria Gődény

Published in: Cancer Imaging | Issue 1/2014

Login to get access

Abstract

As with most cancers the prognosis in pharyngeal and oral cavity cancer largely depends on tumour stage. Physical examination, including endoscopy should be combined with technical radiologic imaging to record the precise extent of tumour. The TNM staging system of the head and neck region is, in fact, an anatomic staging system that describes the anatomic extent of the primary tumour as well as the involvement of regional lymph nodes and distant metastases. Modifications in the TNM staging system should consider not only the expert opinions and published reports in the literature but the technical advances in technology for improved assessment of tumour extent and the shifting paradigms in therapeutic strategies. “T” stage of the tumour is defined by its size, the depth of the invasion and the involvement of vital structures. In the 7th edition of TNM classification, for stage T4 tumors (larger than 4 cm), subcategories a and b were introduced to indicate the involvement of vital structures and their suitability for surgical resection (except for nasopharynx cancer). Nodal metastasis is the most important predictor of outcome for squamous cell cancer of the head and neck.
Better and more reliable methods of pretreatment tumour assessment are therefore crucial to ensure that the clinical assessment of tumor approximates its actual pathologic extent.
CT and MRI are both useful for assessing extensions of pharyngeal- and oral cavity cancer in advanced stage. MRI is superior in visualizing most primary tumour sites.
Appendix
Available only for authorised users
Literature
1.
go back to reference Grégorie V, Lefebvre J, Licitra L, Felip E: Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice: Guidlines for diagnosis, treatment and follow-up. Ann Oncol 2010, 21(7):184–86.CrossRef Grégorie V, Lefebvre J, Licitra L, Felip E: Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice: Guidlines for diagnosis, treatment and follow-up. Ann Oncol 2010, 21(7):184–86.CrossRef
2.
go back to reference Lemort M, Canizares AC, Kampouridis S: Advances in imaging head and neck tumours. Curr Opin Oncol 2006, 18(3):234–239. 10.1097/01.cco.0000219251.15041.b1PubMedCrossRef Lemort M, Canizares AC, Kampouridis S: Advances in imaging head and neck tumours. Curr Opin Oncol 2006, 18(3):234–239. 10.1097/01.cco.0000219251.15041.b1PubMedCrossRef
3.
go back to reference Sobin LH, Gospodarowicz MK, Wittekind CH: TNM Classification of Malignant Tumours. 7th edition. Hoboken NJ: Willey-Blackwell; 2009. Sobin LH, Gospodarowicz MK, Wittekind CH: TNM Classification of Malignant Tumours. 7th edition. Hoboken NJ: Willey-Blackwell; 2009.
4.
go back to reference American Joint Committee on Cancer: AJCC Cancer Staging Handbook. 7th edition. New York: Springer; 2010.CrossRef American Joint Committee on Cancer: AJCC Cancer Staging Handbook. 7th edition. New York: Springer; 2010.CrossRef
5.
go back to reference Nakamura T, Sumi M: Nodal imaging in the neck: recent advances in US, CT and MR imaging of metastatic nodes. Eur Radiol 2007, 17: 1235–41. 10.1007/s00330-006-0490-0PubMedCrossRef Nakamura T, Sumi M: Nodal imaging in the neck: recent advances in US, CT and MR imaging of metastatic nodes. Eur Radiol 2007, 17: 1235–41. 10.1007/s00330-006-0490-0PubMedCrossRef
6.
go back to reference De Bree R, Deurloo EE, Snow GB, Leemans CR: Screening for distant metastases in patients with head and neck cancer. Laryngoscope 2000, 110: 397–401. 10.1097/00005537-200003000-00012PubMedCrossRef De Bree R, Deurloo EE, Snow GB, Leemans CR: Screening for distant metastases in patients with head and neck cancer. Laryngoscope 2000, 110: 397–401. 10.1097/00005537-200003000-00012PubMedCrossRef
7.
go back to reference Loh KS, Brown DH, Baker JT, Gilbert RW, Gullane PJ, Irish JC: A rational approach to pulmonary sreening in newly diagnosed head and neck cancer. Head Neck 2005, 27: 990–994. 10.1002/hed.20261PubMedCrossRef Loh KS, Brown DH, Baker JT, Gilbert RW, Gullane PJ, Irish JC: A rational approach to pulmonary sreening in newly diagnosed head and neck cancer. Head Neck 2005, 27: 990–994. 10.1002/hed.20261PubMedCrossRef
8.
go back to reference Takes RP, Rinaldo A, Silver CE, Piccirillo JF, Haigentz M Jr, Suárez C, Van der Poorten V, Hermans R, Rodrigo JP, Devaney KO, Ferlito A: Future of the TNM classification and staging system in head and neck cancer. Head Neck 2010, 32(12):1693–711. 10.1002/hed.21361PubMedCrossRef Takes RP, Rinaldo A, Silver CE, Piccirillo JF, Haigentz M Jr, Suárez C, Van der Poorten V, Hermans R, Rodrigo JP, Devaney KO, Ferlito A: Future of the TNM classification and staging system in head and neck cancer. Head Neck 2010, 32(12):1693–711. 10.1002/hed.21361PubMedCrossRef
9.
go back to reference Chong VF: Tumour volume measurement in head and neck cancer. Cancer Imaging 2007, 7: 47–49. 10.1102/1470-7330.2007.9002CrossRef Chong VF: Tumour volume measurement in head and neck cancer. Cancer Imaging 2007, 7: 47–49. 10.1102/1470-7330.2007.9002CrossRef
10.
go back to reference Hermans R: Head and Neck Cancer Imaging. 2nd edition. Berlin: Springer; 2012.CrossRef Hermans R: Head and Neck Cancer Imaging. 2nd edition. Berlin: Springer; 2012.CrossRef
12.
go back to reference Vandecaveye V, De Keyzer F, Dirix P, Lambrecht M, Nuyts S, Hermans R, Lambrecht M, Dirix P: Applications of diffusion-weighted magnetic resonance imaging in head and neck squamous cell carcinoma. Neuroradiology 2010, 52(9):773–84. 10.1007/s00234-010-0743-0PubMedCrossRef Vandecaveye V, De Keyzer F, Dirix P, Lambrecht M, Nuyts S, Hermans R, Lambrecht M, Dirix P: Applications of diffusion-weighted magnetic resonance imaging in head and neck squamous cell carcinoma. Neuroradiology 2010, 52(9):773–84. 10.1007/s00234-010-0743-0PubMedCrossRef
13.
go back to reference Sumi M, Sakihama N, Sumi T, Morikawa M, Uetani M, Kabasawa H, Shigeno K, Hayashi K, Takahashi H, Nakamura T: Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. AJNR Am J Neuroradiol 2003, 24: 1627–1634.PubMed Sumi M, Sakihama N, Sumi T, Morikawa M, Uetani M, Kabasawa H, Shigeno K, Hayashi K, Takahashi H, Nakamura T: Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. AJNR Am J Neuroradiol 2003, 24: 1627–1634.PubMed
14.
go back to reference Vandecaveye V, De Keyzer F, Vander Poorten V, Dirix P, Verbeken E, Nuyts S, Hermans R: Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Radiology 2009, 251: 134–46. 10.1148/radiol.2511080128PubMedCrossRef Vandecaveye V, De Keyzer F, Vander Poorten V, Dirix P, Verbeken E, Nuyts S, Hermans R: Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Radiology 2009, 251: 134–46. 10.1148/radiol.2511080128PubMedCrossRef
15.
go back to reference Nuyts S: Defining the tagret for radiotherapy of head and neck cancer. Cancer Imaging 2007, 7: 50–55. 10.1102/1470-7330.2007.9009CrossRef Nuyts S: Defining the tagret for radiotherapy of head and neck cancer. Cancer Imaging 2007, 7: 50–55. 10.1102/1470-7330.2007.9009CrossRef
16.
go back to reference Razek AA, Soliman NY, Elkhamary S, Alsharaway MK, Tawfik A: Role of diffusion-weighted MR imaging in cervical lymphadenopathy. Eur Radiol 2006, 16: 1468–77. 10.1007/s00330-005-0133-xPubMedCrossRef Razek AA, Soliman NY, Elkhamary S, Alsharaway MK, Tawfik A: Role of diffusion-weighted MR imaging in cervical lymphadenopathy. Eur Radiol 2006, 16: 1468–77. 10.1007/s00330-005-0133-xPubMedCrossRef
17.
18.
go back to reference King AD: Multimodality imaging of head and neck cancer. Cancer Imaging 2007, 7: 37–46. 10.1102/1470-7330.2007.9013CrossRef King AD: Multimodality imaging of head and neck cancer. Cancer Imaging 2007, 7: 37–46. 10.1102/1470-7330.2007.9013CrossRef
19.
go back to reference Takes RP, Righi P, Meeuwis CA, Manni JJ, Knegt P, Marres HA, Spoelstra HA, de Boer MF, van der Mey AG, Bruaset I, Ball V, Weisberger E, Radpour S, Kruyt RH, Joosten FB, Laméris JS, van Oostayen JA, Kopecky K, Caldemeyer K, Henzen-Logmans SC, Wiersma-van Tilburg JM, Bosman FT, van Krieken JH, Hermans J, de Jong RJ B: The value of ultrasound-guided fine-needle aspiration biopsy compared to computed tomography in the detection of regional metastases in the clinically negative neck. Int J Radiat Oncol Biol Phys 1998, 40: 1027–32. 10.1016/S0360-3016(97)00953-XPubMedCrossRef Takes RP, Righi P, Meeuwis CA, Manni JJ, Knegt P, Marres HA, Spoelstra HA, de Boer MF, van der Mey AG, Bruaset I, Ball V, Weisberger E, Radpour S, Kruyt RH, Joosten FB, Laméris JS, van Oostayen JA, Kopecky K, Caldemeyer K, Henzen-Logmans SC, Wiersma-van Tilburg JM, Bosman FT, van Krieken JH, Hermans J, de Jong RJ B: The value of ultrasound-guided fine-needle aspiration biopsy compared to computed tomography in the detection of regional metastases in the clinically negative neck. Int J Radiat Oncol Biol Phys 1998, 40: 1027–32. 10.1016/S0360-3016(97)00953-XPubMedCrossRef
20.
go back to reference Tshering Vogel DW, Zbaeren P, Thoeny HC: Cancer of the oral cavity and oropharynx. Cancer Imaging 2010, 10: 62–72.PubMedCrossRef Tshering Vogel DW, Zbaeren P, Thoeny HC: Cancer of the oral cavity and oropharynx. Cancer Imaging 2010, 10: 62–72.PubMedCrossRef
22.
go back to reference Lam P, Au-Yeung KM, Cheng PW, Wei WI, Po-Wing YA, Trendell-Smith N, Li JHC, Li R: Correlating MRI and histologic tumor thickness in the assessment of oral tongue cancer. AJR Am J Roentgenol 2004, 182: 803–808. 10.2214/ajr.182.3.1820803PubMedCrossRef Lam P, Au-Yeung KM, Cheng PW, Wei WI, Po-Wing YA, Trendell-Smith N, Li JHC, Li R: Correlating MRI and histologic tumor thickness in the assessment of oral tongue cancer. AJR Am J Roentgenol 2004, 182: 803–808. 10.2214/ajr.182.3.1820803PubMedCrossRef
23.
go back to reference Chong VF, Ong CK: Nasopharyngeal carcinoma. Eur J Radiol 2008, 66: 437–47. doi:10.1016/ejrad.2008.03.029. PMid:18485650 10.1016/j.ejrad.2008.03.029PubMedCrossRef Chong VF, Ong CK: Nasopharyngeal carcinoma. Eur J Radiol 2008, 66: 437–47. doi:10.1016/ejrad.2008.03.029. PMid:18485650 10.1016/j.ejrad.2008.03.029PubMedCrossRef
24.
go back to reference Ringström E, Peters E, Hasegawa M, Posner M, Liu M, Kelsey KT: Human papillomavirus type 6 and squamous cell carcinoma of the head and neck. Clin Cancer Res 2002, 8(10):3087–92. Ringström E, Peters E, Hasegawa M, Posner M, Liu M, Kelsey KT: Human papillomavirus type 6 and squamous cell carcinoma of the head and neck. Clin Cancer Res 2002, 8(10):3087–92.
25.
go back to reference Hermans R: Squamous Cell Cancer of the Neck. Cambridge: Cambridge University Press; 2008.CrossRef Hermans R: Squamous Cell Cancer of the Neck. Cambridge: Cambridge University Press; 2008.CrossRef
26.
go back to reference Hsu WC, Loevner LA, Karpati R, Ahmed T, Mong A, Battineni ML, Yousem DM, Montone KT, Weinstein GS, Weber RS, Chalian AA: Accuracy of magnetic resonance imaging in predicting absence of fixation of head and neck cancer to the prevertebral space. Head Neck 2005, 27(2):95–100. 10.1002/hed.20128PubMedCrossRef Hsu WC, Loevner LA, Karpati R, Ahmed T, Mong A, Battineni ML, Yousem DM, Montone KT, Weinstein GS, Weber RS, Chalian AA: Accuracy of magnetic resonance imaging in predicting absence of fixation of head and neck cancer to the prevertebral space. Head Neck 2005, 27(2):95–100. 10.1002/hed.20128PubMedCrossRef
27.
go back to reference Hermans R: Staging of laryngeal and hypopharyngeal cancer: value of imaging studies. Cancer Imaging 2008, 8: 94–107. 10.1102/1470-7330.2008.9016CrossRef Hermans R: Staging of laryngeal and hypopharyngeal cancer: value of imaging studies. Cancer Imaging 2008, 8: 94–107. 10.1102/1470-7330.2008.9016CrossRef
28.
go back to reference Som P, Curtin HD: Head and Neck Imaging. Mostby: Imaging-Based Neck Node Level System; 2003:1876–1880. Som P, Curtin HD: Head and Neck Imaging. Mostby: Imaging-Based Neck Node Level System; 2003:1876–1880.
29.
go back to reference Van den Brekel MWM, Castelijns AJ: What the clinician wants to know: surgical perspective and ultrasound for lymph node imaging of the neck. Cancer Imaging 2005, 5(Spec No A):41–49.CrossRef Van den Brekel MWM, Castelijns AJ: What the clinician wants to know: surgical perspective and ultrasound for lymph node imaging of the neck. Cancer Imaging 2005, 5(Spec No A):41–49.CrossRef
30.
go back to reference Castelijns AJ, Van den Brekel MWM: Neck Nodal Disease. Head and Neck Cancer Imaging Medical Radiology. Berlin Heidelberg: Springer; 2006:293–309.CrossRef Castelijns AJ, Van den Brekel MWM: Neck Nodal Disease. Head and Neck Cancer Imaging Medical Radiology. Berlin Heidelberg: Springer; 2006:293–309.CrossRef
31.
go back to reference King AD, Tse GMK, Yuen EHY, To EWH, Vlantis AC, Zee B, Chan ABW, Hasselt AC, Ahuja AT: Comparison of CT and MR imaging for the detection of extranodal neoplastic spread in metastatic neck nodes. Eur J Radiol 2004, 52: 264–270. 10.1016/j.ejrad.2004.03.004PubMedCrossRef King AD, Tse GMK, Yuen EHY, To EWH, Vlantis AC, Zee B, Chan ABW, Hasselt AC, Ahuja AT: Comparison of CT and MR imaging for the detection of extranodal neoplastic spread in metastatic neck nodes. Eur J Radiol 2004, 52: 264–270. 10.1016/j.ejrad.2004.03.004PubMedCrossRef
32.
go back to reference Merritt RM, Williams MF, James TH, Porubsky ES: Detection of cervical metastasis. A meta-analysis comparing computed tomography with physical examination. Arch Otolaryngol Head Neck Surg 1997, 123: 149–152. 10.1001/archotol.1997.01900020027004PubMedCrossRef Merritt RM, Williams MF, James TH, Porubsky ES: Detection of cervical metastasis. A meta-analysis comparing computed tomography with physical examination. Arch Otolaryngol Head Neck Surg 1997, 123: 149–152. 10.1001/archotol.1997.01900020027004PubMedCrossRef
33.
go back to reference De Bondt RBJ, Nelemans PJ, Hofman PA, Casselman JW, Kremer B, van Engelshoven JM, Beets-Tan RG: Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging. Eur J Radiol 2007, 64: 266–272. 10.1016/j.ejrad.2007.02.037PubMedCrossRef De Bondt RBJ, Nelemans PJ, Hofman PA, Casselman JW, Kremer B, van Engelshoven JM, Beets-Tan RG: Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging. Eur J Radiol 2007, 64: 266–272. 10.1016/j.ejrad.2007.02.037PubMedCrossRef
34.
go back to reference Gritzmann N, Grasl MC, Helmer M, Steiner E: Invasion of the carotid artery and jugular vein by lymph node metastases: detection with sonography. AJR 1990, 154: 411–4. 10.2214/ajr.154.2.2105036PubMedCrossRef Gritzmann N, Grasl MC, Helmer M, Steiner E: Invasion of the carotid artery and jugular vein by lymph node metastases: detection with sonography. AJR 1990, 154: 411–4. 10.2214/ajr.154.2.2105036PubMedCrossRef
35.
go back to reference Baghi M, Mack MG, Hambek M, Rieger J, Vogl T, Gstoettner W, Knecht R: The efficacy of MRI with ultrasmall superparamagnetic iron oxide particles (USPIO) in head and neck cancers. Anticancer Res 2005, 25(5):3665–70.PubMed Baghi M, Mack MG, Hambek M, Rieger J, Vogl T, Gstoettner W, Knecht R: The efficacy of MRI with ultrasmall superparamagnetic iron oxide particles (USPIO) in head and neck cancers. Anticancer Res 2005, 25(5):3665–70.PubMed
36.
go back to reference Nason RW, Torchia MG, Morales CM, Thliveris J: Dynamic MR lymphangiography and carbon dye for sentinel lymph node detection: a solution for sentinel lymph node biopsy in mucosal head and neck cancer. Head Neck 2005, 27(4):333–8. 10.1002/hed.20173PubMedCrossRef Nason RW, Torchia MG, Morales CM, Thliveris J: Dynamic MR lymphangiography and carbon dye for sentinel lymph node detection: a solution for sentinel lymph node biopsy in mucosal head and neck cancer. Head Neck 2005, 27(4):333–8. 10.1002/hed.20173PubMedCrossRef
37.
go back to reference Kontio R, Leivo I, Leppanen E, Atula T: Sentinel lymph node biopsy in oral cavity squamous cell carcinoma without clinically evident metastasis. Head Neck 2004, 26(1):16–21. 10.1002/hed.10355PubMedCrossRef Kontio R, Leivo I, Leppanen E, Atula T: Sentinel lymph node biopsy in oral cavity squamous cell carcinoma without clinically evident metastasis. Head Neck 2004, 26(1):16–21. 10.1002/hed.10355PubMedCrossRef
38.
go back to reference Werner JA, Dunne AA, Ramaswamy A, Dalchow C, Behr T, Moll R, Folz BJ, Davis RK: The sentinel node concept in head and neck cancer: solution for the controversies in the N0 neck? Head Neck 2004, 26(7):603–11. 10.1002/hed.20062PubMedCrossRef Werner JA, Dunne AA, Ramaswamy A, Dalchow C, Behr T, Moll R, Folz BJ, Davis RK: The sentinel node concept in head and neck cancer: solution for the controversies in the N0 neck? Head Neck 2004, 26(7):603–11. 10.1002/hed.20062PubMedCrossRef
39.
go back to reference King AD, Ahuja AT, Yeung DK, Fong DK, Lee YY, Lei KI, Tse GM: Malignant cervical lymphadenopathy: diagnostic accuacy of diffusion – weighted MR Imaging. Radiology 2007, 245: 806–813. 10.1148/radiol.2451061804PubMedCrossRef King AD, Ahuja AT, Yeung DK, Fong DK, Lee YY, Lei KI, Tse GM: Malignant cervical lymphadenopathy: diagnostic accuacy of diffusion – weighted MR Imaging. Radiology 2007, 245: 806–813. 10.1148/radiol.2451061804PubMedCrossRef
Metadata
Title
Prognostic factors in advanced pharyngeal and oral cavity cancer; significance of multimodality imaging in terms of 7th edition of TNM
Author
Maria Gődény
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Cancer Imaging / Issue 1/2014
Electronic ISSN: 1470-7330
DOI
https://doi.org/10.1186/1470-7330-14-15

Other articles of this Issue 1/2014

Cancer Imaging 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine